Related references
Note: Only part of the references are listed.Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity
Darko Cerne et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Inhibition of Fatty Acid Synthase Suppresses c-Met Receptor Kinase and Induces Apoptosis in Diffuse Large B-Cell Lymphoma
Shahab Uddin et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Structure and function of eukaryotic fatty acid synthases
Timm Maier et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2010)
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
Quanri Jin et al.
BREAST CANCER RESEARCH (2010)
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
T. Mashima et al.
BRITISH JOURNAL OF CANCER (2009)
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Toshiro Migita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
Pascal Gelebart et al.
BLOOD (2008)
Mantle cell lymphoma: advances in biology and therapy
Mitchell R. Smith
CURRENT OPINION IN HEMATOLOGY (2008)
Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers
Shahab Uddin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Increased fatty acid synthase as a potential therapeutic target in multiple myeloma
Wei-qin Wang et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2008)
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer
Michelangelo Fiorentino et al.
LABORATORY INVESTIGATION (2008)
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels
Catherine A. Tucker et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-κB pathways
Edgar Gil Rizzatti et al.
LEUKEMIA & LYMPHOMA (2008)
Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells
C. P. Pallasch et al.
LEUKEMIA (2008)
Fatty acid synthase inhibitors: new directions for oncology
Steven J. Kridel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics
Pedro Jares et al.
NATURE REVIEWS CANCER (2007)
Up-regulation of Acetyl-CoA carboxylase α and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells
Sarah Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirements
Emma Sandilands et al.
JOURNAL OF CELL SCIENCE (2007)
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Martina Rudelius et al.
BLOOD (2006)
Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas
Lingchen Fu et al.
BLOOD (2006)
Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma
S Shishodia et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFβ signalling pathways
EG Rizzatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
SJ Kridel et al.
CANCER RESEARCH (2004)
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
E Graner et al.
CANCER CELL (2004)
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
JA Menendez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Fatty acid synthase: A metabolic oncogene in prostate cancer?
A Baron et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Inhibition of constitutive NF-κB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis
LV Pham et al.
JOURNAL OF IMMUNOLOGY (2003)
Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach
T Kusakabe et al.
HISTOPATHOLOGY (2002)
Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells
T Kusakabe et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
Share Paper
